106 related articles for article (PubMed ID: 23073360)
1. No positive effect of oral magnesium supplementation in the decreases of inflammation in subjects with prediabetes: a pilot study.
Simental-Mendía LE; Rodríguez-Morán M; Reyes-Romero MA; Guerrero-Romero F
Magnes Res; 2012; 25(3):140-6. PubMed ID: 23073360
[TBL] [Abstract][Full Text] [Related]
2. Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial.
Simental-Mendía LE; Rodríguez-Morán M; Guerrero-Romero F
Arch Med Res; 2014 May; 45(4):325-30. PubMed ID: 24814039
[TBL] [Abstract][Full Text] [Related]
3. Oral magnesium supplementation decreases alanine aminotransferase levels in obese women.
Rodriguez-Hernandez H; Cervantes-Huerta M; Rodriguez-Moran M; Guerrero-Romero F
Magnes Res; 2010 Jun; 23(2):90-6. PubMed ID: 20460213
[TBL] [Abstract][Full Text] [Related]
4. Effect of conjugated linoleic acid supplementation on inflammatory factors and matrix metalloproteinase enzymes in rectal cancer patients undergoing chemoradiotherapy.
Mohammadzadeh M; Faramarzi E; Mahdavi R; Nasirimotlagh B; Asghari Jafarabadi M
Integr Cancer Ther; 2013 Nov; 12(6):496-502. PubMed ID: 23632235
[TBL] [Abstract][Full Text] [Related]
5. Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial.
Guerrero-Romero F; Simental-Mendía LE; Hernández-Ronquillo G; Rodriguez-Morán M
Diabetes Metab; 2015 Jun; 41(3):202-7. PubMed ID: 25937055
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
[TBL] [Abstract][Full Text] [Related]
7. The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients.
Deike E; Bowden RG; Moreillon JJ; Griggs JO; Wilson RL; Cooke M; Shelmadine BD; Beaujean AA
J Ren Nutr; 2012 Nov; 22(6):572-7. PubMed ID: 22285316
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients.
Gharekhani A; Khatami MR; Dashti-Khavidaki S; Razeghi E; Abdollahi A; Hashemi-Nazari SS; Mansournia MA
J Ren Nutr; 2014 May; 24(3):177-85. PubMed ID: 24613294
[TBL] [Abstract][Full Text] [Related]
9. Effect of magnesium supplementation on insulin resistance in humans: A systematic review.
Morais JBS; Severo JS; de Alencar GRR; de Oliveira ARS; Cruz KJC; Marreiro DDN; Freitas BJESA; de Carvalho CMR; Martins MDCCE; Frota KMG
Nutrition; 2017 Jun; 38():54-60. PubMed ID: 28526383
[TBL] [Abstract][Full Text] [Related]
10. Does post-cardiac surgery magnesium supplementation improve outcome?
Carrió ML; Ventura JL; Javierre C; Rodríguez-Castro D; Farrero E; Torrado H; Badia MB; Granados J
Magnes Res; 2012 Dec; 25(4):159-67. PubMed ID: 23262475
[TBL] [Abstract][Full Text] [Related]
11. Not all inflammatory markers are linked to kidney function: results from a population-based study.
Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
[TBL] [Abstract][Full Text] [Related]
12. Positive effect of dietary soy in ESRD patients with systemic inflammation--correlation between blood levels of the soy isoflavones and the acute-phase reactants.
Fanti P; Asmis R; Stephenson TJ; Sawaya BP; Franke AA
Nephrol Dial Transplant; 2006 Aug; 21(8):2239-46. PubMed ID: 16766544
[TBL] [Abstract][Full Text] [Related]
13. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial.
Rodríguez-Moran M; Guerrero-Romero F
Arch Med Res; 2014 Jul; 45(5):388-93. PubMed ID: 24830937
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients.
Malekshahi Moghadam A; Saedisomeolia A; Djalali M; Djazayery A; Pooya S; Sojoudi F
Singapore Med J; 2012 Sep; 53(9):615-9. PubMed ID: 23023905
[TBL] [Abstract][Full Text] [Related]
15. Antiinflammatory effects of L-carnitine supplementation (1000 mg/d) in coronary artery disease patients.
Lee BJ; Lin JS; Lin YC; Lin PT
Nutrition; 2015 Mar; 31(3):475-9. PubMed ID: 25701337
[TBL] [Abstract][Full Text] [Related]
16. Postload hyperglycemia is associated with increased subclinical inflammation in patients with prediabetes.
Colak A; Akinci B; Diniz G; Turkon H; Ergonen F; Yalcin H; Coker I
Scand J Clin Lab Invest; 2013 Aug; 73(5):422-7. PubMed ID: 23767858
[TBL] [Abstract][Full Text] [Related]
17. Flow mediated vasodilation and circulating concentrations of high sensitive C-reactive protein, interleukin-6 and tumor necrosis factor-alpha in normal pregnancy--The Cardiovascular Risk in Young Finns Study.
Saarelainen H; Valtonen P; Punnonen K; Laitinen T; Raitakari OT; Juonala M; Heiskanen N; Lyyra-Laitinen T; Viikari JS; Heinonen S
Clin Physiol Funct Imaging; 2009 Sep; 29(5):347-52. PubMed ID: 19489963
[TBL] [Abstract][Full Text] [Related]
18. Maternal magnesium supplementation reduces intrauterine growth restriction and suppresses inflammation in a rat model.
Roman A; Desai N; Rochelson B; Gupta M; Solanki M; Xue X; Chatterjee PK; Metz CN
Am J Obstet Gynecol; 2013 May; 208(5):383.e1-7. PubMed ID: 23474429
[TBL] [Abstract][Full Text] [Related]
19. Primary familial hypomagnesemia syndrome: a new approach in treatment.
Nesibe A; Sinasi O
J Pediatr Endocrinol Metab; 2012; 25(5-6):599-602. PubMed ID: 22876566
[TBL] [Abstract][Full Text] [Related]
20. Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis.
Tasdogan M; Memis D; Sut N; Yuksel M
J Clin Anesth; 2009 Sep; 21(6):394-400. PubMed ID: 19833271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
